SOPHiA GENETICS officer proposes $12.8K share sale
The notice lists 85,127,825 common shares outstanding and cites two prior sales under a Rule 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
For SOPHiA GENETICS SA (SOPH), Officer George Cardoza filed notice of a proposed sale of 1,592 common shares, with an aggregate market value of $12,847.44. The securities-to-be-sold entry lists Restricted Stock Units as the acquisition type and the issuer as the source. It also lists two prior sales under a Rule 10b5-1 plan: 774 shares on September 21, 2026, for $6,447.42, and 1,592 shares on July 6, 2026, for $8,419.45.
Key Figures
Key Terms
Restricted Stock Units financial
Rule 10b5-1 regulatory
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.